RIVM is actively participating in national and international projects on alternatives to animal testing. On this page, we present an overview of all our (inter)national projects on this topic.
Current projects
| Project | Programme | Fields of expertise | Keywords | Duration |
|---|---|---|---|---|
| Ombion - CPBT | National Growth Fund | 3Rs | pharmaceuticals | in vitro assays | 2025-2035 | |
| CHIASMA | Horizon Europe | SSbD | enivronmental risk assessment | chemicals3Rs | alternatives animal testing | 2024-2027 | |
| Better In-vitro Dosing | Create2Solve | In vitro testing of inhaled substances | difficult-to-test substances | in vitro assays | 3Rs | 2023-2028 |
| MERLON | Horizon Europe | Stem cell, zebrafish | 3Rs | endocrine disruption | chemicals | youth | 2023-2028 |
| INTACT | Strategic Programme RIVM | Non-animal methods | risk assessment | computational toxicology | in vitro assays | chemicals | 2023-2027 | |
| Cells4Thought | Strategic Programme RIVM | Stem cells | Non-animal methods | in vitro assays |chemicals | youth | 2023-2027 |
| NAMs4Nano | EFSA | Zebrafish | nanomaterials | 3Rs | risk assessment | 2023-2027 |
| AFARA | Nationale Wetenschapsagenda | In vitro testing of inhaled substances | Endocrine disruption | non-animal methods | in vitro assays | testing strategy | transition science | 2023-2028 |
| MACRAME | Horizon Europe | In vitro testing of inhaled substances | advanced materials | life-cycle | hazard | 2022-2025 |
| SURPASS | Horizon 2021 | plastics | polymers| safe-and-sustainable-by-design (SSbD) | endocrine disruption | testing strategy | 2022-2025 | |
| Inno4Vac | Horizon 2020 | vaccines | vaccine development | vaccine efficacy | 2021-2027 | |
| PARC | Horizon Europe | In vitro testing of inhaled substances; zebrafish | risk assessment | chemicals | mixtures of chemicals | 2021-2026 |
| RISKHUNT3R | Horizon 2020 | Non-genotoxic carcinogens; stem cells | 3Rs | non-animal methods | 2021-2026 |
| VHP4Safety | Nationale Wetenschapsagenda-Onderzoek op Routes door Consortia | Stem cells; zebrafish; Computational modelling of neural tube defects | Non-animal methods | risk assessment | computational toxicology | in vitro assays | FAIR principles | transition science | 2021-2026 |
| ONTOX | Horizon 2020 | Computational modelling of neural tube defects | computational toxicology | probabilistic risk assessment | 3Rs | 2021-2026 |
| REAL | Strategic Programme RIVM | In vitro testing of inhaled substances | environmental risk factors | In vitro assays | infectious diseases | 2021-2025 |
| DARTBAC | Nationale Wetenschapsagenda | Medical implant safety | safe-by-design | anti-microbial technologies | in vitro assays | 2020-2026 |
| ATHLETE | Horizon 2020 | Stem cells | exposome | environmental risk factors | youth | 2019-2025 |
| Project | Programme | Fields of expertise | Keywords | Duration |
|---|---|---|---|---|
| MOMENTUM | ZonMw, Health~Holland | In vitro testing of inhaled substances | microplastics | in vitro assays | hazard | risk assessment | 2021-2024 |
| Mechanotox | Strategic Programme RIVM | Medical implant safety | mechanotox | biomaterials | in vitro assays | 2020-2024 |
| SAbyNA | Horizon 2020 | SSbD, in vitro testing of inhaled substances | nanomaterials | nano-enabled products | safe-and-sustainable-by-design (SSbD) | hazard testing strategy | inhalation | 2020-2024 |
| COMPAIR | Strategic Programme RIVM | In vitro testing of inhaled substances | environmental risk factors | In vitro assays | infectious diseases | intensive livestock farming | 2019-2022 |
| OrganoVIR | Horizon 2020 | virology | organoids | replacement animal testing | 2019-2022 | |
| PATROLS | Horizon 2020 | In vitro testing of inhaled substances | safe and sustainable use of new technologies and products | nanotechnology | risk assessment | in vitro | 2018-2022 |
| VAC2VAC | IMI | vaccine provision | alternatives animal testing |replacement reduction refinement of animal use | 2016-2022 | |
| EUROMIX | Horizon 2020 | Zebrafish | food safety | safe and sustainable use of chemicals | 2015-2019 |